IBDEI1E5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22501,2)
 ;;=^5009116
 ;;^UTILITY(U,$J,358.3,22502,0)
 ;;=L23.81^^76^969^3
 ;;^UTILITY(U,$J,358.3,22502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22502,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Animal Dander
 ;;^UTILITY(U,$J,358.3,22502,1,4,0)
 ;;=4^L23.81
 ;;^UTILITY(U,$J,358.3,22502,2)
 ;;=^5009123
 ;;^UTILITY(U,$J,358.3,22503,0)
 ;;=L23.0^^76^969^5
 ;;^UTILITY(U,$J,358.3,22503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22503,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,22503,1,4,0)
 ;;=4^L23.0
 ;;^UTILITY(U,$J,358.3,22503,2)
 ;;=^5009115
 ;;^UTILITY(U,$J,358.3,22504,0)
 ;;=B00.1^^76^969^10
 ;;^UTILITY(U,$J,358.3,22504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22504,1,3,0)
 ;;=3^Dermatitis,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,22504,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,22504,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,22505,0)
 ;;=L24.0^^76^969^13
 ;;^UTILITY(U,$J,358.3,22505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22505,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Detergents
 ;;^UTILITY(U,$J,358.3,22505,1,4,0)
 ;;=4^L24.0
 ;;^UTILITY(U,$J,358.3,22505,2)
 ;;=^5009126
 ;;^UTILITY(U,$J,358.3,22506,0)
 ;;=L24.81^^76^969^14
 ;;^UTILITY(U,$J,358.3,22506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22506,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,22506,1,4,0)
 ;;=4^L24.81
 ;;^UTILITY(U,$J,358.3,22506,2)
 ;;=^5009134
 ;;^UTILITY(U,$J,358.3,22507,0)
 ;;=L24.2^^76^969^15
 ;;^UTILITY(U,$J,358.3,22507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22507,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Solvents
 ;;^UTILITY(U,$J,358.3,22507,1,4,0)
 ;;=4^L24.2
 ;;^UTILITY(U,$J,358.3,22507,2)
 ;;=^5009128
 ;;^UTILITY(U,$J,358.3,22508,0)
 ;;=E08.620^^76^969^22
 ;;^UTILITY(U,$J,358.3,22508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22508,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,22508,1,4,0)
 ;;=4^E08.620
 ;;^UTILITY(U,$J,358.3,22508,2)
 ;;=^5002533
 ;;^UTILITY(U,$J,358.3,22509,0)
 ;;=E08.621^^76^969^24
 ;;^UTILITY(U,$J,358.3,22509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22509,1,3,0)
 ;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,22509,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,22509,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,22510,0)
 ;;=T81.33XA^^76^969^27
 ;;^UTILITY(U,$J,358.3,22510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22510,1,3,0)
 ;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
 ;;^UTILITY(U,$J,358.3,22510,1,4,0)
 ;;=4^T81.33XA
 ;;^UTILITY(U,$J,358.3,22510,2)
 ;;=^5054476
 ;;^UTILITY(U,$J,358.3,22511,0)
 ;;=L60.3^^76^969^30
 ;;^UTILITY(U,$J,358.3,22511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22511,1,3,0)
 ;;=3^Dystrophic Nails
 ;;^UTILITY(U,$J,358.3,22511,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,22511,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,22512,0)
 ;;=M71.30^^76^969^25
 ;;^UTILITY(U,$J,358.3,22512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22512,1,3,0)
 ;;=3^Digital Mucous Cyst
 ;;^UTILITY(U,$J,358.3,22512,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,22512,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,22513,0)
 ;;=L30.4^^76^970^10
 ;;^UTILITY(U,$J,358.3,22513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22513,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,22513,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,22513,2)
 ;;=^5009157
